Access to Drugs on Clinical Trial
Oldham, Robert K.
Nature 1987 April 23; 326(6115): 735
Showing items related by title, author, creator and subject.
Schuklenk, Udo; Hogan, Carlton (1996)In this paper we address the question of whether the patients' position is ethically acceptable. At least two different ethical problems need to be analyzed in this regard. One is of a paternalistic nature, and the ...
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study Sofaer, N.; Thiessen, C.; Goold, S.D.; Ballou, J.; Getz, K.A.; Koski, G.; Krueger, R.A.; Weissman, J.S. (2009-03)OBJECTIVES: To report the attitudes and opinions of subjects in US clinical trials about whether or not, and why, they should receive post-trial access (PTA) to the trial drug, care and information. DESIGN: Focus groups, ...